A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

NCT04951622 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: Nipocalimab
DRUG: Placebo
DRUG: Nipocalimab SC-LIV

Sponsor

Janssen Research & Development, LLC